alanosine and Leukemia

alanosine has been researched along with Leukemia* in 1 studies

Other Studies

1 other study(ies) available for alanosine and Leukemia

Article	Year
The treatment of acute leukemia with continuous infusion L-Alanosine. Investigational new drugs, 1983, Volume: 1, Issue:3 L-Alanosine, an antitumor antibiotic was administered by members of the Southwest Oncology Group (SWOG) to 22 patients with resistant acute non-lymphocytic leukemia. The drug was administered by continuous infusion for five days at a starting dose of 125 mg/m2/day. Mucositis was dose-limiting in 15 patients and no marrow aplasia was attained. As administered, L-Alanosine is not an effective single agent in acute leukemia. Topics: Acute Disease; Adolescent; Adult; Aged; Alanine; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Infusions, Parenteral; Leukemia; Male; Middle Aged	1983

Article

Year

The treatment of acute leukemia with continuous infusion L-Alanosine.

Investigational new drugs, 1983, Volume: 1, Issue:3

L-Alanosine, an antitumor antibiotic was administered by members of the Southwest Oncology Group (SWOG) to 22 patients with resistant acute non-lymphocytic leukemia. The drug was administered by continuous infusion for five days at a starting dose of 125 mg/m2/day. Mucositis was dose-limiting in 15 patients and no marrow aplasia was attained. As administered, L-Alanosine is not an effective single agent in acute leukemia.

Topics: Acute Disease; Adolescent; Adult; Aged; Alanine; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Infusions, Parenteral; Leukemia; Male; Middle Aged

1983